SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
SL Science Holding Limited announced successful presentation of preclinical data demonstrating the potent anti-glioblastoma effects of their novel gamma delta T-cell therapy at the 2026 World Congress of Basic and Clinical Pharmacology. The research, conducted in collaboration with Taipei Medical University, JY BioMed, and HeXun Biosciences, showed…